QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,515 signal articles · 85 in last 24h · 108,041 total before filter · latest 1h ago
85last 24h
2588last 7d
485● bullish (7d)
240● bearish (7d)
202publishers
AllMacro224Earnings1619M&A118Regulatory16Product10Analyst25
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Investing.com11d agobullish
Starbucks surges as turnaround plan drives earnings beat and raised guidance

Investing.com -- Starbucks Corporation (NASDAQ:SBUX) reported third-quarter results that surpassed Wall Street expectations, bolstered by accelerating traffic growth in its core North American market and operational improvements under its strategic turnaround effort. The Seattle-based coffee giant lifted its full-year financial outlook, signaling growing momentum in its core operations despite broader macroeconomic uncertainties. Shares of the company rallied 9% in extended trading following the

Meta Stock Slides After Sales Outlook Disappoints Amid Rising AI Costs
Investor's Business Daily11d agobearish
Meta Stock Slides After Sales Outlook Disappoints Amid Rising AI Costs

Meta Platforms stock slid after the social media giant reported second-quarter earnings below expectations. The Facebook parent's sales forecast was below estimates as well, while its AI spending forecast was upped slightly. The Menlo Park, Calif.-based Meta earned $6.18 per share from sales of $60.8 billion for the June quarter, according to a company press release.

Investing.com11d agobearish
Qualcomm falls on weak fourth quarter earnings guidance

SAN DIEGO - Qualcomm Inc (NASDAQ:QCOM) reported third quarter results that beat revenue expectations but missed on earnings, while issuing disappointing guidance for the current quarter that sent shares down 5%.

Meta profit misses estimates on higher costs
Proactive11d agobearish
Meta profit misses estimates on higher costs

Meta Platforms Inc (NASDAQ:META, XETRA:FB2A, SIX:FB) missed second-quarter profit estimates on Wednesday, weighed down by a jump in costs including legal charges, even as revenue grew faster than expected. The social media giant reported earnings per share of $6.18, down 13% year-over-year...

Lam Research (NASDAQ:LRCX) Reports Q2 In Line With Expectations, Stock Soars
StockStory11d agobullish
Lam Research (NASDAQ:LRCX) Reports Q2 In Line With Expectations, Stock Soars

Semiconductor equipment maker Lam Research (NASDAQ:LRCX) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 30% year on year to $6.72 billion. The company expects next quarter’s revenue to be around $8.1 billion, coming in 13.6% above analysts’ estimates. Its non-GAAP profit of $1.82 per share was 8.1% above analysts’ consensus estimates.

Meta stock falls on Q2 earnings miss: What's next for capex?
Yahoo Finance Video11d agobearishVIDEO
Meta stock falls on Q2 earnings miss: What's next for capex?

Meta (META) reported second quarter results on Wednesday after the closing bell. Earnings per share (EPS) came in at $6.18 (compared to analyst estimates of $7.14), and revenue came in at $60.80 billion (compared to analyst estimates of $60.24 billion). Yahoo Finance Senior Business Reporter Ines Ferré takes a closer look at the breaking numbers.

Peabody Energy Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Peabody Energy Q2 Earnings Call Highlights

Peabody Energy (NYSE:BTU) reported a second-quarter net loss attributable to common stockholders of $90.6 million, or $0.74 per diluted share, and adjusted EBITDA of $24 million, as lower U.S. thermal volumes and elevated commissioning costs at its Centurion metallurgical coal mine weighed on result

Boston Scientific Q2 Earnings Call Highlights
MarketBeat11d agoneutral
Boston Scientific Q2 Earnings Call Highlights

Boston Scientific (NYSE:BSX) reported second-quarter 2026 revenue growth at the high end of its guidance range and adjusted earnings per share above expectations, but lowered its full-year outlook as it faces slowing demand in its WATCHMAN left atrial appendage closure business and increased competi